US Patent Issued to VERRA THERAPEUTICS on May 13 for "Methods and compositions for inhibiting ADAM10 biological activities" (North Carolina, New York Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,469, issued on May 13, was assigned to VERRA THERAPEUTICS INC. (Lansing, N.Y.).

"Methods and compositions for inhibiting ADAM10 biological activities" was invented by Marcia L. Moss (Apex, N.C.), Robert Rasmussen (Lansing, N.Y.) and Chris Prince (Ithaca, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are modified isolated ADAM10 modulating peptides and methods of using the same to modulate ADAM10 biological activities, inhibit ADAM10 biological activities associated with diseases, disorders, or conditions in subjects, including but not limited to decreasing inflammation and inhibiting undesirable cell proliferation. In some embodiments...